Cite
HARVARD Citation
Di Renzo, N. et al. (2020). Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese". Cancer medicine. pp. 170-178. [Online].